Search clinical trials for: Second line Small Cell Lung Cancer, (SCLC), Refractory or Sensitive to First line Platinum based che
Total 483907 results
-
Taiho Oncology, Inc.Taiho Pharmaceutical Co., Ltd.TerminatedSmall Cell Lung Cancer (SCLC)Japan, Italy, Germany
-
Intergroupe Francophone de Cancerologie ThoraciqueRecruitingSmall Cell Lung Cancer Extensive StageFrance
-
Jiangsu Simcere Pharmaceutical Co., Ltd.G1 Therapeutics, Inc.Completed
-
AbbVieTerminatedSmall Cell Lung CancerUnited States, Australia, Austria, Belarus, Belgium, Brazil, Bulgaria, Canada, China, Croatia, Czechia, Denmark, Estonia, Finland, France, Germany, Greece, Hong Kong, Hungary, Ireland, Israel, Italy, Japan, Korea, Republic of, Latvia, Lit... and more
-
Zhejiang Cancer HospitalRecruitingSCLC,Extensive StageChina
-
Beijing Chest HospitalNot yet recruitingExtensive-stage Small-cell Lung Cancer
-
Virginia Commonwealth UniversityAbbVieWithdrawnRelapsed Small Cell Lung Cancer | Refractory Small Cell Lung Carcinoma
-
H. Lee Moffitt Cancer Center and Research InstituteActive, not recruitingLung Cancer | Non Small Cell Lung Cancer | Metastatic Lung Cancer | Advanced Cancer | Non-Squamous Non-Small Cell Neoplasm of Lung | Squamous Cell Lung CancerUnited States
-
Shanghai Chest HospitalUnknown
-
Jonsson Comprehensive Cancer CenterTesaro, Inc.; Translational Research in Oncology-U.SRecruitingStage IVA Lung Cancer AJCC v8 | Stage IVB Lung Cancer AJCC v8 | Advanced Malignant Solid Neoplasm | Stage III Lung Cancer AJCC v8 | Stage IV Lung Cancer AJCC v8 | Stage IIIA Lung Cancer AJCC v8 | Stage IIIB Lung Cancer AJCC v8 | Extensive Stage Lung Small Cell Carcinoma | Stage IIIC Lung Cancer AJCC v8United States
-
AHS Cancer Control AlbertaBoehringer Ingelheim; Cross Cancer InstituteWithdrawnSmall Cell Lung Cancer | Platinum-sensitiveCanada
-
Henan Cancer HospitalHuazhong University of Science and TechnologyNot yet recruitingSmall Cell Lung CarcinomaChina
-
First Hospital of Shijiazhuang CityUnknownCarcinoma | Small Cell Lung Cancer | Lung NeoplasmChina
-
AbbVieCompletedSmall Cell Lung CancerUnited States, Australia, Belarus, Belgium, Brazil, Bulgaria, Canada, China, Croatia, Czechia, Denmark, France, Germany, Greece, Hungary, Italy, Japan, Korea, Republic of, Latvia, Mexico, Netherlands, Poland, Portugal, Romania, Russian... and more
-
Fondazione Policlinico Universitario Agostino Gemelli...RecruitingSmall Cell Lung CancerItaly
-
Gemin XCephalonCompletedExtensive-stage Small Cell Lung CancerCanada, United States, United Kingdom, Serbia, Bulgaria, India, Hungary, Czech Republic, Poland, Romania
-
Danish Oncological Lung Cancer GroupTerminatedSmall Cell Lung Cancer | Extensive Disease | First-LineDenmark
-
Hellenic Oncology Research GroupCompleted
-
AbbVie (prior sponsor, Abbott)Genentech, Inc.CompletedSmall Cell Lung Carcinoma | Small Cell Lung CancerUnited States, Canada, United Kingdom
-
Peking Union Medical College HospitalBeijing Chao Yang Hospital; Beijing Hospital; Beijing Chest Hospital; China-Japan...UnknownExtensive-stage Small Cell Lung CancerChina
-
Hirva MamdaniAstraZeneca; Barbara Ann Karmanos Cancer InstituteRecruitingSmall Cell Lung Cancer | SCLC | Extensive Stage Small Cell Lung CancerUnited States
-
CSPC Ouyi Pharmaceutical Co., Ltd.Not yet recruitingSmall Cell Lung Cancer (SCLC)
-
AmgenRecruitingSmall Cell Lung Cancer | Limited Stage Small Cell Lung CancerChina, Japan, Taiwan, Australia, Turkey, United States, Korea, Republic of
-
H. Lee Moffitt Cancer Center and Research InstituteBristol-Myers Squibb; MultiVir, Inc.TerminatedSmall Cell Lung Cancer | Lung Cancer | Relapsed Small Cell Lung CancerUnited States
-
Daiichi SankyoMerck Sharp & Dohme LLCNot yet recruiting
-
National Cancer Center, KoreaBayerTerminatedSmall Cell Lung CancerKorea, Republic of
-
Jeroen Bosch ZiekenhuisUnknownSmall Cell Lung CancerNetherlands
-
Henan Cancer HospitalRecruitingAlotinib Plus Durvalumab-Platinum-Etoposide in First-line Treatment Extensive Small-cell Lung CancerSCLC, Extensive StageChina
-
Xencor, Inc.ICON plcTerminatedSmall Cell Lung Cancer | Merkel Cell CarcinomaUnited States
-
AmgenRecruitingSmall Cell Lung Cancer (SCLC)China, United States, Australia, Netherlands, Taiwan, Spain, Canada, Korea, Republic of, Turkey, Israel, Austria, Japan, France, United Kingdom, Germany, Belgium, Denmark, Czechia, Switzerland, Italy, Hungary, Ireland, Argentina, Brazil, Malays... and more
-
National Cancer Center, KoreaPfizerCompletedLung CancerKorea, Republic of
-
United TherapeuticsCompletedSmall Cell Lung CancerUnited States, Canada, Spain, Australia, Korea, Republic of, France, United Kingdom, Thailand, Malaysia, Hungary, Poland, Taiwan, Philippines, Hong Kong, Lithuania, Georgia, Bulgaria, India, Italy, Romania, Russian Federation, Slo... and more
-
Lee's Pharmaceutical LimitedRecruitingExtensive Stage Small Cell Lung CancerChina
-
ETOP IBCSG Partners FoundationBristol-Myers Squibb; Intergroupe Francophone de Cancerologie Thoracique; Frontier... and other collaboratorsUnknownSmall Cell Lung Cancer | Limited Stage Small Cell Lung CancerSwitzerland, France, Spain, Germany, United Kingdom, Netherlands, Australia, Belgium
-
AGC Biologics S.p.A.Completed
-
AstraZenecaCompletedRefractory Solid Tumours | Relapsed Small Cell Lung Cancer (SCLC)United States, Canada
-
Junling LiUnknownExtensive-Stage Small Cell Lung CancerChina
-
Fujian Cancer HospitalUnknown
-
Charite University, Berlin, GermanyPfizer; Aventis PharmaceuticalsUnknown
-
Biotheus Inc.Recruiting
-
Henan Cancer HospitalJiangsu HengRui Medicine Co., Ltd.UnknownSmall Cell Lung Cancer Extensive StageChina
-
RayzeBio, Inc.RecruitingSCLC,Extensive StageUnited States, Puerto Rico
-
Li Zhang, MDRecruitingSmall Cell Lung Cancer | Lung Cancer | DurvalumabChina
-
You LuAstraZenecaActive, not recruitingLung Cancer | Extensive-stage Small-cell Lung Cancer | DurvalumabChina
-
Maastricht Radiation OncologyCompletedSmall Cell Lung CancerNetherlands
-
Se-Hoon LeeTerminatedAZD2811 and Durvalumab (MEDI4736) Combination Therapy in Relapsed Small Cell Lung Cancer (SUKSES-N5)SCLC, RecurrentKorea, Republic of
-
AmgenNot yet recruitingSmall-Cell Lung Cancer | Extensive-Stage Small-Cell Lung Cancer
-
AstraZenecaActive, not recruitingSmall Cell Lung CancerUnited States, Canada, Germany, Italy, Netherlands, Spain, Belgium, Poland, Taiwan, Vietnam, Korea, Republic of, Czechia, India, Japan, Russian Federation, Turkey, China, United Kingdom, Argentina
-
H. Lee Moffitt Cancer Center and Research InstituteCompletedSmall Cell Lung CancerUnited States